Skip to main content
AAN.com

Abstract

Objective: To evaluate the relevance of hypometabolism in the hippocampal head to the pathophysiology of memory impairment.
Background: Neurofunctional imaging studies with an image reslicing technique provided by using software suggest that dysfunction of the amygdalohippocampal system causes memory impairment. However, metabolic and morphologic profiles of the whole hippocampal formation have not been evaluated in detail.
Methods: By tilting the gantry of a high-resolution PET scanner in a plane parallel to the hippocampal longitudinal axis determined beforehand by MRI, we performed quantitative measurement of glucose metabolism in the subdivisions of the hippocampal formation (head, body, tail) in 10 patients of normal intelligence with pure amnesia, in eight patients with AD, and in eight normal subjects.
Results: Although the volumes of the amygdala and hippocampal formation in pure amnesics were not different significantly from those of normal subjects, glucose metabolism in the head of the hippocampus was significantly lower in pure amnesics. In patients with AD, marked hypometabolism was found extending to the amygdala, the hippocampal head, and the parietotemporal cortex, along with amygdalohippocampal atrophy.
Conclusion: Hippocampal head dysfunction plays an important role in memory impairment in amnesic patients. Further metabolic impairment over the amygdalohippocampal system and the surrounding association cortex reflects the pathophysiology of AD.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950-2967.
2.
Zola-Morgan S, Squire LR, Amaral DG, Suzuki WA. Lesions of perirhinal and parahippocampal cortex that spare the amygdala and hippocampal formation produce severe memory impairment. J Neurosci 1989;9:4355-4370.
3.
Squire LR. Mechanisms of memory. Science 1986;232:1612-1619.
4.
Fukuyama H, Harada K, Yamauchi H, et al. Coronal reconstruction images of glucose metabolism in Alzheimer's disease. J Neurol Sci 1991;106:128-134.
5.
Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET. J Nucl Med 1996;37:1159-1165.
6.
Nybäck H, Nyman H, Blomqvist G, et al. Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991;54:672-678.
7.
Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-506.
8.
Newman SK, Warrington EK, Kennedy AM, Rossor MN. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J Neurol Neurosurg Psychiatry 1994;57:967-972.
9.
Soininen HS, Partanen K, Pitkänen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment. Neurology 1994;44:1660-1668.
10.
Mishkin M. Memory in monkeys severely impaired by combined but not by separate removal of amygdala and hippocampus. Nature 1978;273:297-298.
11.
Duyckaerts C, Derouesne C, Signoret JL, et al. Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 1985;18:314-319.
12.
Duvernoy HM. The human hippocampus: an atlas of applied anatomy. New York: Springer-Verlag, 1988.
13.
Hyman BT, Van Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 1990;40:1721-1730.
14.
Kartsounis LD, Rudhe P, Stevens JM. Bilateral lesions of CA1 and CA2 fields of the hippocampus are sufficient to cause a severe amnesic syndrome in humans. J Neurol Neurosurg Psychiatry 1995;59:95-98.
15.
Beaurain J, Dormont D, Semah F, et al. Hippocampal formations imaging with axial sections parallel to their longitudinal axis. Magn Reson Imaging 1994;12:139-148.
16.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17.
Berg L. Clinical dementia rating. Psychopharmacol Bull 1988;24:637-639.
18.
Wechsler D. The Wechsler Adult Intelligence Scale-Revised. San Antonio: Psychological Corporation, 1981.
19.
Wechsler D. Wechsler Memory Scale-Revised. San Antonio: Psychological Corporation, 1987.
20.
Mohs RC, Rosen WG, Davis KL. The Alzheimer's Disease Assessment Scale; an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19:448-450.
21.
Bronen RA, Cheung G. MRI of the normal hippocampus. Magn Reson Imaging 1991;9:497-500.
22.
Ouchi Y, Nobesawa S, Okada H, et al. Glucose metabolism of the human hippocampal formation in the hippocampal long axis plane measured by PET. J Cereb Blood Flow Metab 1997;17:S218. Abstract.
23.
Yamashita T, Uchida H, Okada H, et al. Development of a high resolution PET. IEEE Trans Nucl Sci 1990;37:594-599.
24.
Huang SC, Phelps ME, Hoffman EJ, et al. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
25.
Baron JC, Miyazawa H. Use of positron emission tomography to assess effects of brain lesions in experiment subhuman primates. In: Michaelconn P, ed. Methods in neurosciences. San Diego: Academic Press, 1991:429-441.
26.
Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750.
27.
Ouchi Y, Okada H, Kakiuchi T, et al. Co-registration between PET and MRI in rat brain. Ann Nucl Med 1996;10:S143. Abstract.
28.
Duara R, Grady C, Haxby J, et al. Human brain glucose utilization and cognitive function in relation to age. Ann Neurol 1984;16:702-713.
29.
Jagust WJ, Eberling JL, Richardson BC, et al. The cortical topography of temporal lobe hypometabolism in Alzheimer's disease. Brain Res 1993;629:189-198.
30.
Frackowiak RS, Pozzilii C, Legg NJ, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981;104:753-778.
31.
Foster NL, Chase TN, Fedio P, et al. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 1983;33:961-965.
32.
Benson DF, Kuhl DE, Hawkins RA, et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983;40:711-714.
33.
Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
34.
Baulac M, Lehericy S, Chiras J. MR volumetric measurement of the hippocampal formation and amygdala in the mild stages of Alzheimer's disease. Neurology 1993;43:212. Letter.
35.
Fazio F, Perani D, Gilardi MC, et al. Metabolic impairment in human amnesia: a PET study of memory networks. J Cereb Blood Flow Metab 1992;12:353-358.
36.
Meltzer CC, Zubieta JK, Brandt J, et al. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996;47:454-461.
37.
Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:472-481.
38.
Vanderwolf CH, Leung LW, Cooley RK. Pathway through cingulate, neo- and entorhinal cortices mediate atropine-resistant hippocampal rhythmical slow activity. Brain Res 1985;347:58-73.
39.
Ridley RM, Timothy CJ, Maclean CJ, Baker HF. Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus. Neuroscience 1995;67:263-275.
40.
Rempel-Clower NL, Zola-Morgan S, Squire LR, Amaral DG. Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation. J Neurosci 1996;16:5233-5255.
41.
Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 1990;83:445-457.
42.
Morris JS, Frith CD, Perrett DI, et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996;383:812-815.
43.
Scott SK, Young AW, Calder AJ, et al. Impaired auditory recognition of fear and anger following bilateral amygdala lesions. Nature 1997;385:254-257.
44.
Dicks D, Myers RE, Kling A. Uncus and amygdala lesions: effects on social behavior in the free ranging rhesus monkey. Science 1969;165:69-71.
45.
Herzog AG, Kemper TL. Amygdala changes in aging and dementia. Arch Neurol 1980;37:625-629.
46.
Herzog AG, Van Hoesen GW. Temporal neocortical afferent connections to the amygdala in the rhesus monkey. Brain Res 1976;115:57-69.
47.
Cummings JL, Benson DF. Dementia of the Alzheimer's type: an inventory of diagnostic clinical features. J Am Geriatr Soc 1986;34:12-19.
48.
Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988;45:1187-1190.

Information & Authors

Information

Published In

Neurology®
Volume 51Number 1July 1998
Pages: 136-142
PubMed: 9674792

Publication History

Published online: July 1, 1998
Published in print: July 1998

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Y. Ouchi, MD, PhD
From the Positron Medical Center (Dr. Ouchi and S. Nobezawa) and the Department of Neurosurgery, Hamamatsu Medical Center (Dr. Kaneko); and the Central Research Laboratory (H. Okada, E. Yoshikawa, and M. Futatsubashi), Hamamatsu Photonics K.K., Hamakita, Shizuoka, Japan.
S. Nobezawa, RT
From the Positron Medical Center (Dr. Ouchi and S. Nobezawa) and the Department of Neurosurgery, Hamamatsu Medical Center (Dr. Kaneko); and the Central Research Laboratory (H. Okada, E. Yoshikawa, and M. Futatsubashi), Hamamatsu Photonics K.K., Hamakita, Shizuoka, Japan.
H. Okada, BA
From the Positron Medical Center (Dr. Ouchi and S. Nobezawa) and the Department of Neurosurgery, Hamamatsu Medical Center (Dr. Kaneko); and the Central Research Laboratory (H. Okada, E. Yoshikawa, and M. Futatsubashi), Hamamatsu Photonics K.K., Hamakita, Shizuoka, Japan.
E. Yoshikawa, BA
From the Positron Medical Center (Dr. Ouchi and S. Nobezawa) and the Department of Neurosurgery, Hamamatsu Medical Center (Dr. Kaneko); and the Central Research Laboratory (H. Okada, E. Yoshikawa, and M. Futatsubashi), Hamamatsu Photonics K.K., Hamakita, Shizuoka, Japan.
M. Futatsubashi, BA
From the Positron Medical Center (Dr. Ouchi and S. Nobezawa) and the Department of Neurosurgery, Hamamatsu Medical Center (Dr. Kaneko); and the Central Research Laboratory (H. Okada, E. Yoshikawa, and M. Futatsubashi), Hamamatsu Photonics K.K., Hamakita, Shizuoka, Japan.
M. Kaneko, MD
From the Positron Medical Center (Dr. Ouchi and S. Nobezawa) and the Department of Neurosurgery, Hamamatsu Medical Center (Dr. Kaneko); and the Central Research Laboratory (H. Okada, E. Yoshikawa, and M. Futatsubashi), Hamamatsu Photonics K.K., Hamakita, Shizuoka, Japan.

Notes

Address correspondence and reprint requests to Dr. Yasuomi Ouchi, Positron Medical Center, Hamamatsu Medical Center, 5000 Hirakuchi, Hamakita, Shizuoka 434, Japan.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Lower Availability of Mitochondrial Complex I in Anterior Cingulate Cortex in Autism: A Positron Emission Tomography Study, American Journal of Psychiatry, 180, 4, (277-284), (2023).https://doi.org/10.1176/appi.ajp.22010014
    Crossref
  2. In vivo Illustration of Altered Dopaminergic and GABAergic Systems in Early Parkinson's Disease, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.880407
    Crossref
  3. A multi‐hit hypothesis for an APOE4 ‐dependent pathophysiological state , European Journal of Neuroscience, 56, 9, (5476-5515), (2022).https://doi.org/10.1111/ejn.15685
    Crossref
  4. Microstructural and Cerebral Blood Flow Abnormalities in Subjective Cognitive Decline Plus: Diffusional Kurtosis Imaging and Three-Dimensional Arterial Spin Labeling Study, Frontiers in Aging Neuroscience, 13, (2021).https://doi.org/10.3389/fnagi.2021.625843
    Crossref
  5. The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence, Journal of Clinical Medicine, 9, 1, (206), (2020).https://doi.org/10.3390/jcm9010206
    Crossref
  6. In vivo imaging of dopamine D1 receptor and activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study, Molecular Psychiatry, 26, 9, (4958-4967), (2020).https://doi.org/10.1038/s41380-020-0784-7
    Crossref
  7. Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment, Current Alzheimer Research, 16, 9, (852-860), (2019).https://doi.org/10.2174/1567205016666190805155230
    Crossref
  8. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa, NeuroImage: Clinical, 23, (101928), (2019).https://doi.org/10.1016/j.nicl.2019.101928
    Crossref
  9. Sevoflurane Induces Learning and Memory Impairment in Young Mice Through a Reduction in Neuronal Glucose Transporter 3, Cellular and Molecular Neurobiology, 40, 6, (879-895), (2019).https://doi.org/10.1007/s10571-019-00779-0
    Crossref
  10. Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy, Scientific Reports, 8, 1, (2018).https://doi.org/10.1038/s41598-018-23127-6
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share